Stay updated on DCVax-L for Newly Diagnosed GBM Clinical Trial
Sign up to get notified when there's something new on the DCVax-L for Newly Diagnosed GBM Clinical Trial page.

Latest updates to the DCVax-L for Newly Diagnosed GBM Clinical Trial page
- CheckyesterdayChange DetectedA site-wide announcement says NIH is transitioning to the term “Super Intelligence” in place of “Artificial Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check7 days agoChange DetectedThe ClinicalTrials.gov page continues to display a 403 Forbidden error; its footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check14 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check35 days agoChange DetectedThe study page now displays a 403 Forbidden error, with the content replaced by a standard header/footer indicating restricted access. The previous detailed study information and navigation sections have been removed from view.SummaryDifference17%

- Check57 days agoChange DetectedRevision tag on the page was updated from v3.6.5 to v3.6.6, indicating a minor metadata update to the study record. This change reflects an updated version identifier rather than substantive alterations to study data or content.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page now presents the full Study Details with sponsor, investigators, locations, design, and outcomes, and includes PubMed publications and MeSH terms, replacing the previous error page.SummaryDifference87%

Stay in the know with updates to DCVax-L for Newly Diagnosed GBM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DCVax-L for Newly Diagnosed GBM Clinical Trial page.